Form 4 Tracker
Sue-Jean Lin

Director · 3 filings · Latest: Jun 15, 2026

Arcutis Biotherapeutics, Inc.
Stevanato Group S.p.A.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ARQT
Sue-Jean LinDirectorJun 15, 2026
Sale
$24.384,946$120.6K27,567
ARQT
Sue-Jean LinJun 15, 2026
Proposed Sale
$24.384,946$120.6K
ARQT
Sue-Jean LinNov 24, 2025
Proposed Sale
$30.7825,272$778.0K